AzTrials
AzTrials

Critically IllNCT03539653

The Effect of Gastric Antrum Ultrasonography on Early Stage of Enteral Nutrition in Critically Ill Patients.

An observational study of Critically Ill, run by Kang Yan at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the effect of Gastric Antrum Ultrasonography on Early Stage of Enteral Nutrition in Critically Ill Patients. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Critically Ill
How many people
220 participants
Where
1 siteChina
Study dates
1 May 2018to 1 Jul 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients in ICU who need enteral nutrition,and the length of stay in icu>3days

Who may be able to join

  • All patients who need enteral nutrition (through the nose) in ICU ; the length of stay in ICU > 3 days;

Who cannot join

  • <18 years old; >90 years old; gastrointestinal surgery history; small blow nutrition; BMI>30kg/m2; pregnancy; prone position>4hours a day

Trial locations and contacts

1 site in 1 country.

Yan Kang, M.D. contact

18980601566

kang_yan_123@163.com

Wanhong Yin, M.D. contact

13518106758

doctorwhy@126.com

China1 site, 1 recruiting
  • West China Hospital

    Chengdu, Sichuan, 610041

    Yan Kang, M.D, 18980601566, kang_yan_123@163.com

    Recruiting

Other trials in China

About this study

The purpose of this study is to investigate the effect of Gastric Antrum Ultrasonography on Early Stage of Enteral Nutrition in Critically Ill Patients.

Conditions
Critically Ill
Medical subject headings
Critical Illness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incidence of tube feeding intolerance during ICU

    incidence of tube feeding intolerance during ICU,such as vomit,diarrhea,Bloating.

    Measured: during ICU,an average of 7 days

Secondary outcomes (8)
  1. gastric residual volume

    gastric residual volume during ICU

    Measured: during ICU,an average of 7 days

  2. nutrition indicators

    nutrition indicators during ICU,such as prealbumin

    Measured: through study completion,an average of 7 days

  3. the first clinical parameters of prognosis

    incidence of regurgitation during enteral nutrition

    Measured: through study completion,an average of 7 days

  4. the second clinical parameters of prognosis

    ventilator-associated pneumonia

    Measured: through study completion,an average of 7 days

  5. the third clinical parameters of prognosis

    length of mechanic ventilation during ICU

    Measured: through study completion,an average of 7 days

  6. the forth clinical parameters of prognosis

    length of stay in ICU

    Measured: through study completion,an average of 7 days

  7. the fifth clinical parameters of prognosis

    hospital mortality

    Measured: through study completion,an average of 15 days

  8. the sixth clinical parameters of prognosis

    hospitalization costs during ICU

    Measured: through study completion,an average of 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2018
  2. Study start1 May 2018
  3. Primary completion1 May 2019 (estimated)
  4. Study completion1 Jul 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
220 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03539653
Sponsor's protocol ID
GUS
Status last verified
Oct 2018
First submitted
23 Apr 2018
Last updated
9 Oct 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA, Gervasio JM, Sacks GS, Roberts PR, Compher C; Society of Critical Care Medicine; American Society for Parenteral and Enteral Nutrition. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):159-211. doi: 10.1177/0148607115621863. No abstract available.

    PubMed 26773077
  • Warren M, McCarthy MS, Roberts PR. Practical Application of the Revised Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: A Case Study Approach. Nutr Clin Pract. 2016 Jun;31(3):334-41. doi: 10.1177/0884533616640451. Epub 2016 Apr 12.

    PubMed 27072854
  • Sharma V, Gudivada D, Gueret R, Bailitz J. Ultrasound-Assessed Gastric Antral Area Correlates With Aspirated Tube Feed Volume in Enterally Fed Critically Ill Patients. Nutr Clin Pract. 2017 Apr;32(2):206-211. doi: 10.1177/0884533616681530. Epub 2016 Dec 16.

    PubMed 28362573
  • Liu Y, Gao YK, Yao L, Li L. Modified B-ultrasound method for measurement of antral section only to assess gastric function and guide enteral nutrition in critically ill patients. World J Gastroenterol. 2017 Jul 28;23(28):5229-5236. doi: 10.3748/wjg.v23.i28.5229.

    PubMed 28811717
  • Bisinotto FM, Pansani PL, Silveira LA, Naves AA, Peixoto AC, Lima HM, Martins LB. Qualitative and quantitative ultrasound assessment of gastric content. Rev Assoc Med Bras (1992). 2017 Feb;63(2):134-141. doi: 10.1590/1806-9282.63.02.134.

    PubMed 28355374
  • Van de Putte P, Perlas A. Ultrasound assessment of gastric content and volume. Br J Anaesth. 2014 Jul;113(1):12-22. doi: 10.1093/bja/aeu151. Epub 2014 Jun 3.

    PubMed 24893784

Questions about this trial

What is this clinical trial studying?

An observational study of Critically Ill, run by Kang Yan at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yan Kang, M.D. (18980601566, kang_yan_123@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incidence of tube feeding intolerance during ICU (time frame: during ICU,an average of 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03539653, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in